HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sarah Hibbitts Selected Research

gp100(280-288) melanoma antigen peptide

11/2004Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule.
11/2004Competition among peptides in melanoma vaccines for binding to MHC molecules.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sarah Hibbitts Research Topics

Disease

5Melanoma (Melanoma, Malignant)
11/2007 - 11/2003
2Testicular Neoplasms (Testicular Cancer)
11/2007 - 03/2005
2Neoplasms (Cancer)
03/2005 - 11/2003
2Tetanus
11/2004 - 11/2003
1Vitiligo
11/2003

Drug/Important Bio-Agent (IBA)

5VaccinesIBA
11/2007 - 11/2003
5Peptides (Polypeptides)IBA
11/2007 - 11/2003
3HLA-A2 Antigen (HLA A2 Antigen)IBA
11/2004 - 11/2003
2HLA Antigens (Human Leukocyte Antigens)IBA
11/2007 - 11/2004
2Protein Subunit VaccinesIBA
11/2007 - 11/2004
2Proteins (Proteins, Gene)FDA Link
11/2007 - 03/2005
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2005 - 11/2003
2Monatide (IMS 3015)IBA
03/2005 - 11/2003
2HLA-A3 Antigen (HLA A3 Antigen)IBA
11/2004 - 11/2003
2Monophenol Monooxygenase (Tyrosinase)IBA
11/2004 - 11/2003
2gp100(280-288) melanoma antigen peptideIBA
11/2004 - 11/2004
1AntigensIBA
11/2007
1EpitopesIBA
03/2005
1gp100(17-25) peptideIBA
11/2004
1Interleukin-2 (IL2)IBA
11/2004
1HLA-A1 Antigen (HLA A1 Antigen)IBA
11/2003
1EmulsionsIBA
11/2003